Tumor cell immunohistochemistry examination can be seen markers CD3 and granzyme B positive, NK series of tumors can be seen CD56 +, T series of tumors can be seen CD5 +, CD8 +, NK and T series of tumors there is no obvious clinicopathological difference, so clinical diagnosis and treatment cannot be separated from the two. This evidence concerns the gene CD8A and neoplasm.